These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 2009316)
1. A method for determination of iododeoxyuridine substitution of thymidine using reversed-phase high-performance liquid chromatography. Yabuki H; Nath R Cell Prolif; 1991 Jan; 24(1):33-47. PubMed ID: 2009316 [TBL] [Abstract][Full Text] [Related]
2. Technique for detection of DNA nucleobases by reversed-phase high-performance liquid chromatography optimized for quantitative determination of thymidine substitution by iododeoxyuridine. Belanger K; Collins JM; Klecker RW J Chromatogr; 1987 Jun; 417(1):57-63. PubMed ID: 3624403 [TBL] [Abstract][Full Text] [Related]
3. Incorporation of iododeoxyuridine into DNA of granulocytes in patients. Belanger K; Klecker RW; Rowland J; Kinsella TJ; Collins JM Cancer Res; 1986 Dec; 46(12 Pt 1):6509-12. PubMed ID: 3779659 [TBL] [Abstract][Full Text] [Related]
4. Iododeoxyuridine chemosensitization of cis-diamminedichloroplatinum(II) in human bladder cancer cells. Chi KH; Kunugi KA; Kinsella TJ Cancer Res; 1994 May; 54(10):2701-6. PubMed ID: 8168100 [TBL] [Abstract][Full Text] [Related]
5. Fluorodeoxyuridine modulation of the incorporation of iododeoxyuridine into DNA of granulocytes: a phase I and clinical pharmacological study. Speth PA; Kinsella TJ; Belanger K; Klecker RW; Smith R; Rowland JB; Collins JM Cancer Res; 1988 May; 48(10):2933-7. PubMed ID: 2965970 [TBL] [Abstract][Full Text] [Related]
6. Modulation of IdUrd-DNA incorporation and radiosensitization in human bladder carcinoma cells. Kunugi KA; Vazquez-Padua MA; Miller EM; Kinsella TJ Cancer Res; 1990 Aug; 50(16):4962-7. PubMed ID: 2199032 [TBL] [Abstract][Full Text] [Related]
7. Measurement of thymidine replacement in patients with high grade gliomas, head and neck tumors, and high grade sarcomas after continuous intravenous infusions of 5-iododeoxyuridine. Cook JA; Glass J; Lebovics R; Bobo H; Pass H; DeLaney TF; Oldfield EH; Mitchell JB; Glatstein E; Goffman TE Cancer Res; 1992 Feb; 52(3):719-25. PubMed ID: 1732059 [TBL] [Abstract][Full Text] [Related]
8. Effects of leucovorin on idoxuridine cytotoxicity and DNA incorporation. Greene RF; Collins JM Cancer Res; 1990 Oct; 50(20):6652-6. PubMed ID: 2208128 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of base excision repair potentiates iododeoxyuridine-induced cytotoxicity and radiosensitization. Taverna P; Hwang HS; Schupp JE; Radivoyevitch T; Session NN; Reddy G; Zarling DA; Kinsella TJ Cancer Res; 2003 Feb; 63(4):838-46. PubMed ID: 12591735 [TBL] [Abstract][Full Text] [Related]
10. Modulation of the metabolism and cytotoxicity of iododeoxyuridine by 5'-amino-5'-deoxythymidine. Fischer PH; Weddle MA; Mossie RD Mol Pharmacol; 1983 May; 23(3):709-16. PubMed ID: 6865913 [TBL] [Abstract][Full Text] [Related]
11. Selective radiosensitization of drug-resistant MutS homologue-2 (MSH2) mismatch repair-deficient cells by halogenated thymidine (dThd) analogues: Msh2 mediates dThd analogue DNA levels and the differential cytotoxicity and cell cycle effects of the dThd analogues and 6-thioguanine. Berry SE; Davis TW; Schupp JE; Hwang HS; de Wind N; Kinsella TJ Cancer Res; 2000 Oct; 60(20):5773-80. PubMed ID: 11059773 [TBL] [Abstract][Full Text] [Related]
12. Thermal sensitivity and radiosensitization in V79 cells after BrdUrd or IdUrd incorporation. Raaphorst GP; Vadasz JA; Azzam EI Radiat Res; 1984 Apr; 98(1):167-75. PubMed ID: 6718691 [TBL] [Abstract][Full Text] [Related]
13. Kinetics of cell labeling and thymidine replacement after continuous infusion of halogenated pyrimidines in vivo. Rodriguez R; Ritter MA; Fowler JF; Kinsella TJ Int J Radiat Oncol Biol Phys; 1994 Apr; 29(1):105-13. PubMed ID: 8175417 [TBL] [Abstract][Full Text] [Related]
14. Fluorodeoxyuridine improves imaging of human glioblastoma xenografts with radiolabeled iododeoxyuridine. Dupertuis YM; Vazquez M; Mach JP; De Tribolet N; Pichard C; Slosman DO; Buchegger F Cancer Res; 2001 Nov; 61(21):7971-7. PubMed ID: 11691821 [TBL] [Abstract][Full Text] [Related]
15. Enhancement of radiation damage in cellular DNA following unifilar substitution with iododeoxyuridine. Fornace AJ; Dobson PP; Kinsella TJ Int J Radiat Oncol Biol Phys; 1990 Apr; 18(4):873-8. PubMed ID: 2323975 [TBL] [Abstract][Full Text] [Related]
16. Improved high-affinity monoclonal antibody to iododeoxyuridine. Vanderlaan M; Watkins B; Thomas C; Dolbeare F; Stanker L Cytometry; 1986 Nov; 7(6):499-507. PubMed ID: 3096672 [TBL] [Abstract][Full Text] [Related]
17. Selective incorporation of iododeoxyuridine into DNA of hepatic metastases versus normal human liver. Speth PA; Kinsella TJ; Chang AE; Klecker RW; Belanger K; Collins JM Clin Pharmacol Ther; 1988 Oct; 44(4):369-75. PubMed ID: 3168389 [TBL] [Abstract][Full Text] [Related]
18. Potentiation of chemotherapy cytotoxicity following iododeoxyuridine incorporation in Chinese hamster cells. Russo A; DeGraff W; Kinsella TJ; Gamson J; Glatstein E; Mitchell JB Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1371-4. PubMed ID: 3759557 [TBL] [Abstract][Full Text] [Related]
19. Iododeoxyuridine incorporation and radiosensitization in three human tumor cell lines. Uhl V; Phillips TL; Ross GY; Bodell WJ; Rasmussen J Int J Radiat Oncol Biol Phys; 1992; 22(3):489-94. PubMed ID: 1735685 [TBL] [Abstract][Full Text] [Related]
20. Unlabelled iododeoxyuridine increases the rate of uptake of [125I]iododeoxyuridine in human xenografted glioblastomas. Dupertuis YM; Xiao WH; De Tribolet N; Pichard C; Slosman DO; Bischof Delaloye A; Buchegger F Eur J Nucl Med Mol Imaging; 2002 Apr; 29(4):499-505. PubMed ID: 11914888 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]